ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

M.D. Anderson Wins 11th SPORE Grant.

July 3, 2008

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997

Cancer Policy: Coffey Letter Lists Research Initiatives That Justify Increase

December 19, 1997

In Brief: Reagan Asks $955 Million fr NCI In FY 1983, Up $13 Million Over Current Level; PDQ Is Coming

February 12, 1982

Cancergrams Cost $840 Year For All

December 2, 1977